Jeffrey P. Rydin net worth and biography

Jeffrey Rydin Biography and Net Worth

Director of Alphatec

Jeffrey P. Rydin has served as a director since June 2017 and as a Special Advisor to the Board since September 2016. Mr. Rydin has spent more than 27 years in the medical device and healthcare industries. Prior to joining Alphatec as Special Advisor to the Board, Mr. Rydin served as Chief Sales Officer of Ellipse Technologies, Inc., a medical technology company, from September 2015 until its purchase by NuVasive, Inc. in February 2016. Before joining Ellipse, Mr. Rydin served as President of Global Sales at NuVasive (October 2011 to March 2013), where he was responsible for NuVasive’s worldwide sales efforts, including the oversight of strategic sales development, sales administration, Area Vice Presidents and sales training. Prior to his position of President of Global Sales, he served as Executive Vice President of Sales—Americas and Senior Vice President, U.S. Sales since joining NuVasive in December 2005. Prior to joining NuVasive, Mr. Rydin served as Area Vice President, Sales (US Southeast region) at DePuy Spine, Inc. from January 2003 to December 2005. Mr. Rydin also served as Vice President of Sales at Orquest, Inc. from December 2001 to January 2003, Director of Sales at Symphonix Devices, Inc. from April 2000 to December 2001 and Director of Sales at General Surgical Innovations, Inc. from October 1996 to March 2000. Mr. Rydin also has served in various executive and leadership sales roles at General Surgical Innovations, Baxter Healthcare, US Surgical Corporation and Xerox. He currently serves as director of DuraStat, LLC. Mr. Rydin received a B.A. degree in Social Ecology from the University of California, Irvine.

What is Jeffrey P. Rydin's net worth?: The estimated net worth of Jeffrey P. Rydin is at least $8.20 million as of November 3rd, 2025. Mr. Rydin owns 385,441 shares of Alphatec stock worth more than $8,202,184 as of December 4th. This net worth approximation does not reflect any other investments that Mr. Rydin may own. Learn More about Jeffrey P. Rydin's net worth.
How do I contact Jeffrey P. Rydin?: The corporate mailing address for Mr. Rydin and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on Jeffrey P. Rydin's contact information.
Has Jeffrey P. Rydin been buying or selling shares of Alphatec?: During the past quarter, Jeffrey P. Rydin has sold $3,864,000.00 in Alphatec stock. Most recently, Jeffrey P. Rydin sold 200,000 shares of the business's stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $19.32, for a transaction totalling $3,864,000.00. Following the completion of the sale, the director now directly owns 385,441 shares of the company's stock, valued at $7,446,720.12. Learn More on Jeffrey P. Rydin's trading history.
Who are Alphatec's active insiders?: Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), David Demski (Director), Jason Hochberg (Director), Craig Hunsaker (EVP), Mortimer III (Director), John Koning (Chief Financial Officer), Scott Lish (SVP), Tyson Marshall (General Counsel & Corporate Secretary), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Jeffrey Rydin (Director), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.
Are insiders buying or selling shares of Alphatec?: In the last twelve months, insiders at the medical technology company sold shares 47 times. They sold a total of 3,582,443 shares worth more than $63,320,843.20. The most recent insider tranaction occured on December, 1st when CEO Patrick Miles sold 100,000 shares worth more than $2,211,000.00. Insiders at Alphatec own 20.9% of the company. Learn More about insider trades at Alphatec.
Information on this page was last updated on 12/1/2025.

Jeffrey P. Rydin Insider Trading History at Alphatec

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/3/2025	Sell	200,000	$19.32	$3,864,000.00	385,441
12/17/2019	Sell	20,000	$7.06	$141,200.00	243,746

Jeffrey P. Rydin Buying and Selling Activity at Alphatec

Alphatec Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $21.28

$21.14

$21.57

50 Day Range

MA: $17.66

$13.14

$23.23

2 Week Range

Now: $21.28

$8.69

$22.66

Volume

1,282,338 shs

Average Volume

2,121,082 shs

Market Capitalization

$3.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08